GPT Healthcare Limited owns and operates a chain of multispecialty hospitals under the ILS Hospitals brand name in India. The company offers healthcare services, including internal medicine and diabetology; nephrology, such as renal transplants; laparoscopic and general surgery; gynecology and obstetrics; critical care; gastroenterology; orthopedics and joint replacement; interventional cardiology; neurology; neurosurgery; pediatrics; neonatology; robotic-assisted surgery; bariatric surgery; hematology; psychology; dermatology; and ENT services. It also operates clinics and pharmacies; provides academic and diagnostic services; and sale of pharmaceutical products. The company was incorporated in 1989 and is based in Kolkata, India. GPT Healthcare Limited operates as a subsidiary of GPT Sons Pvt. Ltd.
| Current Price | ₹133.55 |
|---|---|
| Market Cap | ₹1,155 Cr |
| Sector | Health Care > Health Care Equipment and Services > Health Care Providers and Services |
| Sub-Industry | Health Care Facilities > Hospitals and Healthcare Centers |
| P/E Ratio | 27.2 |
| Return on Equity | 16.32% |
| 52-Week Range | ₹115.00 – ₹175.00 |
| Beta (1Y) | 0.45 |
| Dividend Yield | 2.14% |
| Revenue | ₹126 Cr |
|---|---|
| Net Profit | ₹13 Cr |
| EPS (Basic) | ₹1.55 |
| Basis | standalone |
Figures in ₹ crore, parsed from the company's exchange filing (XBRL).
1. Healthcare Service-100%
GPT Healthcare Limited is trading at ₹133.55, with a market capitalisation of ₹1,155 Cr.
GPT Healthcare Limited operates in the Health Care > Health Care Equipment and Services > Health Care Providers and Services space (Health Care Facilities > Hospitals and Healthcare Centers).
GPT Healthcare Limited has a P/E of 27.2 and a return on equity of 16.32%.
In Q1 FY27, GPT Healthcare Limited reported revenue of ₹126 Cr and net profit of ₹13 Cr, with basic EPS of ₹1.55 (standalone, parsed from the company's exchange filing).